Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Association of NCCN-Recommended Posttreatment Surveillance With Outcomes in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma

Association of NCCN-Recommended Posttreatment Surveillance With Outcomes in Patients With... Key PointsQuestionIs National Comprehensive Cancer Network (NCCN)–recommended posttreatment clinical surveillance in patients with human papillomavirus (HPV)–associated oropharyngeal squamous cell carcinoma (SCC) associated with improvements in recurrence detection and survival outcomes? FindingsIn this cohort study of 233 patients with HPV–associated oropharyngeal SCC, only 1 asymptomatic recurrence was detected of 3358 posttreatment clinical surveillance visits, and adherence to the recommended schedule did not seem to improve survival. MeaningThe findings of this study suggest that reduction of the NCCN-recommended posttreatment clinical surveillance schedule for HPV–associated oropharyngeal SCC is warranted. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Otolaryngology - Head & Neck Surgery American Medical Association

Association of NCCN-Recommended Posttreatment Surveillance With Outcomes in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma

Loading next page...
 
/lp/american-medical-association/association-of-nccn-recommended-posttreatment-surveillance-with-Bc2QVHeP8S

References (20)

Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
2168-6181
eISSN
2168-619X
DOI
10.1001/jamaoto.2019.1934
Publisher site
See Article on Publisher Site

Abstract

Key PointsQuestionIs National Comprehensive Cancer Network (NCCN)–recommended posttreatment clinical surveillance in patients with human papillomavirus (HPV)–associated oropharyngeal squamous cell carcinoma (SCC) associated with improvements in recurrence detection and survival outcomes? FindingsIn this cohort study of 233 patients with HPV–associated oropharyngeal SCC, only 1 asymptomatic recurrence was detected of 3358 posttreatment clinical surveillance visits, and adherence to the recommended schedule did not seem to improve survival. MeaningThe findings of this study suggest that reduction of the NCCN-recommended posttreatment clinical surveillance schedule for HPV–associated oropharyngeal SCC is warranted.

Journal

JAMA Otolaryngology - Head & Neck SurgeryAmerican Medical Association

Published: Oct 8, 2019

There are no references for this article.